Trial · NCT02052414
Results by group33
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 33
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Numeric Pain Rating System (NPRS) | Gralise (Gabapentin ER) | NPRS Baseline (Visit 1) | 7.29 | Standard Deviation 1.51 | units on a scale |
| Numeric Pain Rating System (NPRS) | Gralise (Gabapentin ER) | NPRS on Week 4 (Visit 2) | 4.72 | Standard Deviation 2.44 | units on a scale |
| Numeric Pain Rating System (NPRS) | Gralise (Gabapentin ER) | NPRS on week 8 (Visit 3) | 3.95 | Standard Deviation 2.18 | units on a scale |
| Numeric Pain Rating System (NPRS) | Gralise (Gabapentin ER) | NPRS on Week 12 (Visit 4) | 3.83 | Standard Deviation 2.05 | units on a scale |
| Numeric Pain Rating System (NPRS) | Gralise (Gabapentin ER) | NPRS on week 15 (Visit 5) | 6.94 | Standard Deviation 2.08 | units on a scale |
| Medical Outcome Study (MOS) Sleep Questionnaires | Gralise (Gabapentin ER) | Sleep Quantity Baseline | 5.86 | Standard Error 1.65 | Hours |
| Medical Outcome Study (MOS) Sleep Questionnaires | Gralise (Gabapentin ER) | Sleep Quantity week 4 | 7.17 | Standard Error 1.62 | Hours |
| Medical Outcome Study (MOS) Sleep Questionnaires | Gralise (Gabapentin ER) | Sleep quantity week 8 | 6.81 | Standard Error 1.81 | Hours |
| Medical Outcome Study (MOS) Sleep Questionnaires | Gralise (Gabapentin ER) | Sleep quantity week 12 | 7.04 | Standard Error 0.72 | Hours |
| Medical Outcome Study (MOS) Sleep Questionnaires | Gralise (Gabapentin ER) | Sleep quantity week 15 | 6.23 | Standard Error 1.71 | Hours |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Extremity Swelling | 2 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Weight Gain | 2 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Drowsy | 8 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Dizzy | 3 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Irritability | 3 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Dry Eyes | 2 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Pain | 1 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Mood Changes | 2 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Difficulty Concentrating | 2 | participants | |
| Self Reported Side Effects. | Gralise (Gabapentin ER) | Dry Mouth | 1 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02052414/results